2-Amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) is a mammary gland carcinogen present in the human diet. Herein, the expression of estrogen receptor alpha (ERa), estrogen receptor beta (ERb) and progesterone receptor (PR) was examined in mammary gland carcinomas induced by PhIP in female Sprague--Dawley rats. Quantitative real-time polymerase chain reaction demonstrated that ERa, ERb and PR were statistically elevated by 3-, 4-and 8-fold in carcinomas compared with normal mammary glands. By immunohistochemistry, carcinomas showed statistically higher nuclear expression of all three steroid receptors with the majority of carcinomas showing at least 10% of epithelial cells stained for ERa (49/55, 89%), ERb (41/55, 75%) and PR (48/55, 87%). Furthermore, the level of expression of the three steroid hormone receptors was positively correlated with each other across the bank of carcinomas (Spearman analysis, P 5 0.05). The expression of ERa in carcinomas was associated with tumor grade, extent of nuclear pleomorphism and cellular proliferation as measured by proliferating cell nuclear antigen (PCNA) and phospho-Rb immunostaining (Spearman analysis, P 5 0.05). Confocal microscopy was used to measure the percentage of epithelial cells showing nuclear colocalization of receptors, PCNA, and cyclin D1. Colocalization of the receptors, and the colocalization of the receptors with PCNA and cyclin D1 was strikingly higher in carcinomas than in the normal mammary gland. In carcinoma cells, 37% of ERa positive epithelial cells were colocalized with PCNA in contrast to just 0.25% of cells in the normal mammary gland. The findings from this study indicate that ERa, ERb and PR were coupregulated and nuclear localized in epithelial cells from rat mammary carcinomas compared with normal mammary glands, and that the co-upregulation was positively correlated with proliferation and cell cycle progression in carcinomas.
Introduction
The rat mammary gland is a widely used model for studying the pathogenesis, therapy and chemoprevention of breast cancer (1--3) . Rat mammary gland carcinomas resemble human breast cancer in histopathogenesis, pathological features and hormone-dependence. Experimental rat mammary gland carcinogens 7,12-dimethylbenz [a] anthracene (DMBA) and N-nitrosomethylurea (NMU) induce carcinomas that are generally hormone-dependent (1--4) and estrogen and progesterone receptor (PR) positive (5--9) . Ovarian steroids and their receptors are important in normal mammary gland development and carcinogenesis and estrogen is a major player in this regard (10--13) . It has been known for many years that ERa positive breast cancer cell lines proliferate in response to estradiol (14) . In human breast cancer, the status of ERa expression provides a clinical biomarker of prognosis and response to therapies such as treatment with the antiestrogen tamoxifen (15) .
2-Amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP), a carcinogenic heterocyclic amine, is prevalent in the western diet and implicated as an etiological factor in human breast cancer (16, 17) . In addition to epidemiological evidence linking PhIP exposure to an increased risk of breast cancer, PhIP is a known mammary gland carcinogen in rats (18--20) . Further supporting its possible involvement in human breast cancer, PhIP has recently been shown to have estrogenic activity in a human breast cancer cell line (21) .
The molecular alterations in PhIP-induced rat mammary gland cancers have been examined in several studies (22--27) . Similar to a significant percentage of human breast cancers, PhIP-induced carcinomas show deregulation of the cyclin D1/cdk4 retinoblastoma pathway and enhanced cellular proliferation (27) . Ovarian hormones induce the recruitment of quiescent mammary epithelial cells into the cell cycle, G 1 progression and G 1 /S transition. One effect of estrogen on the cell cycle involves nuclear receptor ERa-mediated regulation of cyclin D1 transcription (28) . Deregulation of estrogencontrolled pathways of proliferation has been implicated in breast carcinogenesis (10--12) . In the normal mammary gland a relatively small number of cells express receptors for estrogen and progesterone, and the expression of steroid receptors and proliferation-associated markers are almost mutually exclusive among the epithelial cells (10, 11, 13) . However, breast cancer epithelial cells show a concomitant increase in nuclear expression of ERa and proliferation markers. These findings have supported the notion that while steroid hormones regulate proliferation in normal breast epithelial cells through a paracrine mechanism, presumably via steroid hormone-mediated release of growth factors from cells that subsequently stimulate proliferation in adjacent cells, deregulation in cancer epithelial cells involves a shift to an autocrine mechanism by which steroid hormones stimulate proliferation in the same cells harboring the receptors (12) .
The role of steroid hormone receptors in PhIP-induced rat mammary gland cancer and whether the expression of steroid hormone receptors is deregulated and associated with proliferation and cyclin D1 expression have not yet been examined. The current study examines the expression of steroid hormone receptors ERa, ERb and PR, as well as markers of cell-cycle proliferation and progression across a large bank of PhIPinduced rat mammary gland carcinomas.
Materials and methods
Rat mammary gland samples and PhIP-induced carcinomas PhIP-induced rat mammary gland carcinomas were archival samples that were generated in prior studies (18, 20, 23) . Age-matched control rat mammary gland samples were also collected in these studies. Briefly, adolescent Sprague--Dawley rats had received 10 doses of PhIP (75 mg/kg), once a day for 10 days. Carcinomas and normal mammary gland samples were snap-frozen and stored at À80
C and stored in formalin-fixed paraffin embedded blocks at 4 C. Classification and grading of carcinomas were based on a scoring system adapted from the Scarff--Bloom--Richardson grading scheme as previously described (25) with the modification that proliferation was evaluated by proliferating cell nuclear antigen (PCNA) immunostaining instead of by mitotic figures. The highest grade, poorly differentiated carcinomas tended to show a solid growth pattern with marked nuclear pleomorphism and a higher percentage of PCNA positive cells. RNA isolation and quantitative real-time polymerase chain reaction Total RNA was isolated using TRIzol extraction reagent (Invitrogen Life Technology, Carlsbad, CA). The major stromal contaminant in the normal mammary gland is adipose tissue. Fat was effectively removed from normal mammary gland samples by avoiding the fatty layer after chilling the homogenate on ice prior to centrifugation at 4 C and by using phenol--chloroform extraction. The RNA was treated with DNA-free TM (Ambion, Inc., Austin, TX) prior to reverse transcription to avoid genomic DNA contamination. Reverse transcription was carried out with ThermoScript TM RT--PCR System (Invitrogen Life Technology, Carlsbad, CA) using random primers according to manufacture instruction. An aliquot of 1 mg of RNA was used to synthesize cDNA and 1 ml of RT was used for the following experiment.
Antibodies
Relative quantitation of gene expression was determined by quantitative real-time polymerase chain reaction (PCR) analysis with the ABI Prism 7900 Sequence Detection System (PE Applied Biosystems, Foster City, CA) using the comparative method as described previously (26) . Standard curves were generated with various amounts of cDNA from the NMU rat mammary carcinoma cell line (26) . Reactions were also routinely run without template as a negative control. The sequence of primers and probes of ERa, ERb and PR for quantitative real-time PCR are given in Table I . TaqMan rodent GAPDH set (Applied Biosystems, Foster City, CA) was used for normalization of the target genes. GAPDH was chosen as the reference because it was consistently and reproducibly expressed in all samples. Relative gene expression was derived by the method outlined in ABI Prism Sequence Detection System User Bulletin #2.
Immunohistochemistry
Immunostaining was carried out using the Universal DAKO LSAB2 System. Briefly, 5 mm thick tissue sections were deparaffinized and rehydrated. Prior to being blocked by hydrogen peroxide, antigen retrieval was performed by microwaving. Slides were incubated sequentially with primary antibodies overnight at 4 C and then with HRP-labeled secondary antibodies for 30 min at room temperature. Antibody concentrations were as recommended by the manufacture. Negative controls were run without the primary antibody. Sections were developed using AEC substrate and counterstained with Mayer's hematoxylin. A total of 55 PhIP-induced rat mammary carcinomas and 5 study control rat mammary gland samples were stained. Cells with redcolored nuclei staining were scored as positive and the percentage of positively stained cells was calculated as previously described (26, 27) .
Confocal microscopy
Using antibodies for ERa, ERb, PR, cyclin D1 and PCNA, nuclear colocalization was determined by confocal microscopy. Sections were blocked with 5% bovine serum albumin in phosphate buffered saline, followed by an overnight incubation of the primary antibody at 4 C and fluorescent secondary antibody for 1 h at 37 C . The sections were air dried and mounted in Vectashield with DAPI (H-1200, Vector, Burlingame, CA). Tissue sections incubated with only secondary antibody served as the negative controls. Sections were analyzed for colocalization with a Zeiss LSM 510 NLO Confocal Microscope (Carl Zeiss Inc., Thornwood, NY). For each pair of the primary antibodies, 3--5 images were analyzed. The number of positively single stained (red or green only), double stained (both red and green, i.e. yellow) nuclei, and total number of epithelial cells within a field as indicated by DAPI single staining (blue) were counted using Image J software (NIH, Bethesda, MD).
Statistical analysis
Statistical analysis including Student's t-test (one-or two-tailed) and the Spearman Rank Order Correlation was carried out, where indicated, using SigmaStat Statistical Software, version 2.0 (Jandel, San Rafael CA). Statistical significance was assumed at P 5 0.05.
Results

mRNA expression and immunostaining of ERa, ERb and PR
The mRNA expression of ERa, ERb and PR in normal mammary glands and mammary carcinomas were measured by quantitative real-time PCR. As shown in Table II , ERa, ERb and PR showed statistically significantly higher mRNA expression in mammary carcinomas than did normal mammary glands (Student's t-test, P 5 0.05). The elevation of expression in carcinomas was highest for PR, followed by ERb and ERa.
The ERa, ERb and PR receptor proteins were detected in the nuclei of epithelial cells of both carcinoma and the normal mammary gland by immunohistochemistry (Figure 1 ). In carcinomas, ERa and PR positively stained epithelial cells were mainly distributed around the ductal elements, while ERb positive epithelial cells were located diffusely throughout the tumor. The percentage of epithelial cell nuclei stained for ERa, ERb, PR and PCNA was on average 2-to 4-fold higher in the carcinomas than in the normal mammary gland. By immunostaining a range in the level of steroid receptor expression was observed among the carcinomas, and the majority of carcinomas showed levels of epithelial cell expression 410% (Figure 2) . A 10% level has been considered a standard cut off value for defining ER positive or negative carcinomas in human breast cancers (29) . Rat mammary gland carcinomas have been considered ovarian hormone nonresponsive at approximately 510% of positively stained cells (5) . A few carcinomas (6/55, 11%) showed ERa nuclear staining levels comparable with normal mammary glands and 510% while the majority showed nuclear expression levels in the range of 11--38%. A similar range in the percentage of nuclear expression observed for ERb and PR and 14/55 (25%) and 7/55 (13%) carcinomas, respectively, showed 510% nuclear staining for both receptors. All ERa negative carcinomas were also ERb negative, whereas eight ERb negative carcinomas were considered ERa positive. By Spearman analysis, a statistically positive correlation in the level of expression was observed between ERa and ERb, and between each of the estrogen receptors and PR (Table III) . ERa expression was statistically positively correlated with proliferation and cell cycle markers including PCNA, pRb and cdk4, as well as with the degree of nuclear pleomorphism and tumor grade. Neither ERb nor PR expression was statistically significantly correlated with PCNA or cdk4 expression but ERb was weakly correlated with pRb. PR but not ERb was statistically positively correlated with nuclear pleomorphism and tumor grade.
Colocalization of ERa, ERb, PR, and cell cycle and proliferation markers
The colocalization of steroid hormone receptors, cyclin D1 and PCNA was examined in normal mammary glands and carcinomas by confocal microscopy. Representative images are shown in Figure 3 (and Supplementary Figures 4 and 5) . In the normal mammary gland, relatively few normal epithelial cells showed colocalization of steroid receptors with the cell cycle markers (Table IV) 
Discussion
This study examined the expression of steroid hormone receptors ERa, ERb and PR in PhIP-induced rat mammary gland carcinomas. The mRNA and protein expressions of all three receptors were upregulated in carcinomas in comparison with the normal rat mammary gland. The majority of PhIP-induced rat mammary gland cancers were positive for ERa by immunostaining. Only 6 of 55 carcinomas showed levels of ERa expression at or below the level found in normal mammary gland and could be regarded as ER negative. The predominance of Quantitative real-time PCR and calculations using the comparative C T method were described in Materials and methods. Range (in parentheses) is derived from the standard error of DC T . Normal mammary glands were from untreated age-matched rats. P-values are calculated by the Student's t-test. Fig. 1 . Immunohistochemical detection of ERa, ERb, PR and PCNA in normal rat mammary gland (upper images) and PhIP-induced rat mammary gland carcinomas (lower images). Magnification 400Â.
Steroid hormone receptor in rat mammary carcinomas
ERa positive over ERa negative carcinomas is consistent with the studies of other chemically induced rat mammary gland cancers (5--9) . Across the bank of PhIP-induced carcinomas, the level of nuclear expression of ERa and PR were statistically associated; carcinomas with higher ERa tended to show higher PR. The expression of ERa and PR was also found to be colocalized in~30% of epithelial cells in the carcinomas. The correlation between ERa and PR expression fits the widely accepted paradigm that PR is a downstream target of ERa activation (29) . The results of the study indicate that the overwhelming majority of PhIP-induced rat mammary gland cancers possess an active ERa. In rat mammary gland carcinomas, the level of expression of ERa was positively correlated by Spearman analysis with proliferation as assessed by PCNA, phosphorylated pRb, and cdk4 expression. Furthermore, there was a positive correlation between ERa expression and nuclear pleomorphism and between ERa and histologic grade. Our findings in rats are consistent with previous studies on the effect of soy diets on DMBA-induced rat mammary gland cancers that reported an association between ERa expression, PCNA and differentiation grade (6, 7) . In humans, ERa negative breast carcinomas are considered more proliferative and aggressive than ERa positive carcinomas (29--32) . Nevertheless, there are subclasses of human breast carcinomas that show an association between proliferation and ERa expression (32--34) . Rat mammary gland carcinomas in general are less aggressive than human breast cancers, tend to show a papillary or cribriform growth pattern, greater cellular differentiation and a low frequency of metastasis (2) . The high percentage of ERa positive carcinomas in rats seems to be consistent with the lower grade appearance of these tumors in comparison with many human breast cancers.
The ERb is a second estrogen receptor with different ligand binding specificity and distinct functions from ERa (35, 36) . The ERb has been detected in human and rat mammary gland carcinomas as well as in normal mammary gland (5,8,37--41) . As observed previously with rat mammary gland carcinomas induced by hormones or DMBA (5,8) , the immunohistochemical pattern of ERb expression in PhIP-induced carcinomas is different from ERa. The epithelial cells showing ERb expression are found more diffusely throughout the carcinoma while ERa positive cells are located primarily around the lumen in putative luminal epithelial cells. We found that~21% of epithelial cells in PhIP-induced carcinomas showed nuclear colocalized expression of both ERa and ERb using confocal microscopy. This finding indicates that the expression of these receptors colocalizes in a minority of epithelial cells and supports the notion that the function of each receptor is largely unique.
The role that ERb might play in mammary gland carcinogenesis is not yet known with certainty. Several studies have suggested potentially opposing actions of ERa and ERb on the expression of genes involved in cell-cycle regulation and proliferation (42--44) . ERb may also possibly influence the expression of proliferation markers in human breast cancers (45) . In our study, however, ERb did not appear to independently influence proliferation in carcinomas. The level of expression of ERb tended to parallel the expression of ERa. Furthermore, all ERa negative tumors were also ERb negative. Unlike ERa, ERb was not statistically associated with PCNA or cdk4 expression, and although ERb was positively associated with the levels of pRb by Spearman analysis, the association was weaker than the association between ERa and pRb. Furthermore, there was no statistical difference in PCNA or pRb expression between ERa positive/ERb positive and ERa positive/ERb negative carcinomas (Student's t-test, P 4 0.05). The results suggest that ERa rather than ERb is the main estrogen receptor driving proliferation in PhIP-induced rat mammary gland carcinomas. The majority of human breast cancers have been shown to be positive for both ERa and ERb and studies have suggested that ERb may be a favorable prognostic factor in human breast cancer (35, 38, 40, 46, 47) . PhIP-induced rat mammary gland carcinomas appear to be similar to a percentage of human breast cancers in the coexpression of both estrogen receptors, and rat mammary gland carcinomas would be akin to human breast cancers with good prognosis. Further studies are clearly required to evaluate the impact of ERb expression on rat mammary gland carcinogenesis.
As observed in human breast cancer (11, 12) , we observed differences in nuclear colocalization of steroid receptors in normal rat mammary gland and carcinomas. While the percentage of epithelial cells showing nuclear colocalization of any three of the steroid hormone receptors and PCNA was low in normal mammary gland, the percentage of epithelial cells showing colocalization increased well over 50-fold in Fig. 3 . Representative confocal microscopy images showing nuclear colocalization of ERa with PR, ERb, cyclin D1 and PCNA in PhIP-induced rat mammary gland carcinomas. The single color of red or green stained nuclei represents one antibody. The overlay of the red and green color produces a yellow color that represents the colocalized staining of the ERa to another protein (third column). Magnification, 630Â. The percentage of total epithelial cells counted that stained positive for both red (antibody 1) and green (antibody 2) fluors (i.e. colocalized yellow nuclear staining). The values represent the means AE standard error of 3--5 different normal glands or mammary carcinomas. The total cells for normal mammary gland ranged from 627 to 2539, the total epithelial cells for carcinomas ranged from 1777 to 4915. mammary gland carcinomas. Consistent with studies in human breast cancer, there appeared to be a paracrine to autocrine shift in the regulation of proliferation in PhIP-induced rat mammary gland carcinomas such that a higher percentage of epithelial cells now showed coexpression of steroid hormone receptors with PCNA. Our studies also showed an increased nuclear localization of the steroid hormone receptors with cyclin D1 during carcinogenesis. Estrogens and progesterone have been shown to promote persistent cyclin D1 activation during the G1 phase of the cell cycle (28, 44) . Cyclin D1 appears to be a focal point for the cell-cycle deregulation occurring in rat mammary gland carcinomas and there is mounting evidence for the central role of cyclin D1 specifically in PhIP-induced rat mammary gland cancers (23, 27) . For example, PhIP-induced rat mammary gland cancers show a high frequency of mutations in H-ras, a gene linked to the cell cycle via cyclin D1, and overexpression of Stat5a, a gene that transactivates the cyclin D1 promoter, as well as overexpression and amplification of cyclin D1 itself (22, 25, 27) . Steroid hormone receptors may also partly mediate the aberrant proliferation in PhIP-induced rat mammary gland cancer via cyclin D1. Continued effort to clarify the molecular mechanisms of rat mammary gland cancer especially with regard to steroid hormone receptors expression is expected to provide further insight into factors involved in breast cancer development.
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